Search research articles
Contact Us
Filters
Showing results (251-260 of 286) with videos related to
Page
of 29
Sort By:
Frontiers in Immunology
|
March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy
Jair Bar, Raya Leibowitz, Niels Reinmuth, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
Noelle L Williams, Evan J Wuthrick, Hyun Kim, et al.
The Lancet. Oncology
|
July 19, 2024
Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial
Yaacov R Lawrence, Marcin Miszczyk, Laura A Dawson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 20, 2013
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary
Paul E Wallner, Mitchell S Anscher, Christopher A Barker, et al.
Urology Case Reports
|
October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
Hyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 286) with videos related to
Sort By:
Page
of 29
Frontiers in Immunology
|
March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy
Jair Bar, Raya Leibowitz, Niels Reinmuth, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
Noelle L Williams, Evan J Wuthrick, Hyun Kim, et al.
The Lancet. Oncology
|
July 19, 2024
Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial
Yaacov R Lawrence, Marcin Miszczyk, Laura A Dawson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 20, 2013
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary
Paul E Wallner, Mitchell S Anscher, Christopher A Barker, et al.
Urology Case Reports
|
October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
Hyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Page
of 29